Patient diversity in clinical trials: How to meet the need
We need a new paradigm for increasing diversity in clinical trials....
07 July, 2022
Diversity
It’s time to harness data to improve clinical trial patient diversity
We need to widen the data net and do a better job of analyzing those data to identify clinical trials participants from previously ignored patient populations....
06 July, 2022
How oncology clinical trials can use data to dig deeper on diversity
Although many clinical trial sponsors are broadly aware of the need for more diverse participation, most still struggle to implement specific, structural changes that will help trials better represent the wider population....
09 June, 2022
Honoring ‘Medical Laboratory Professionals Week’
In honor of “Medical Laboratory Professionals Week” (April 24-30), we at the University of Wisconsin–Madison Clinical Research Office would like to express our gratitude to all of the lab professionals in our clinical research community!...
24 April, 2022
FDA recommends sponsors plan to include race, ethnicity in clinical trial design
The US Food and Drug Administration (FDA) is recommending sponsors include a plan to increase diversity when proposing clinical trial designs for investigational products to agency reviewers....
13 April, 2022
UW Health earns top score in Human Rights Campaign Foundation’s 2022 Healthcare Equality Index
UW Health received a top score of 100 in the "Health Equality Index, the nation’s foremost benchmarking survey of healthcare facilities on policies and practices dedicated to the equitable treatment and inclusion of their LGBTQ+ patients, visitors and employees....
28 March, 2022
UW plays a leading role in vaccine clinical trials in the fight against COVID-19
In a little over 18 months, UW-Madison has conducted COVID vaccine and treatment trials in all age groups (ages 7 months- 96 years old). These trials are a representation of all people (race, religion, sex) in Wisconsin- nearly 700 participants....
01 March, 2022
Patient diversity in clinical studies: The key to advancing precision medicine
Until we have better inclusion of participants with diverse demographics and behaviors – and can analyze that data in conjunction with prognostic data – we won’t know the effectiveness of a product for these large, underrepresented populations....
22 February, 2022